ArticlebioRxiv : the preprint server for biology2025
A High-throughput Multi-Species Platform Using Biolayer Interferometry Immunosorbent Assay (BLI-ISA) as an Alternative to Indirect ELISA for Vaccine Development.
Ti Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.